Protalix Biotherapeutics, Inc. (PLX)
1.975
+0.02
(+0.77%)
USD |
NYAM |
Jun 09, 16:00
1.975
0.00 (0.00%)
After-Hours: 16:05
Protalix Biotherapeutics EPS Diluted (Quarterly) : 0.2206 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.023 |
| Altimmune, Inc. | -0.1813 |
| Humacyte, Inc. | -0.089 |
| Amgen, Inc. | 3.344 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 18.32M |
| Revenue (Quarterly) | 33.75M |
| Total Expenses (Quarterly) | 15.43M |
| Enterprise Value | 114.61M |
| Gross Profit Margin (Quarterly) | 87.77% |
| Profit Margin (Quarterly) | 54.27% |
| Earnings Yield | 9.28% |
| Operating Earnings Yield | 12.31% |
| Normalized Earnings Yield | 9.281 |